Bermejo-Jambrina M, et al.EMBO J. 2021 Sep 12:e106765. doi: 10.15252/embj.2020106765. Online ahead of print.EMBO J. 2021.PMID: 34510494.
.
Fasting blood glucose as a predictor of mortality: Lost in translation.
Palliyaguru DL, Shiroma EJ, Nam JK, Duregon E, Vieira Ligo Teixeira C, Price NL, Bernier M, Camandola S, Vaughan KL, Colman RJ, Deighan A, Korstanje R, Peters LL, Dickinson SL, Ejima K, Simonsick EM, Launer LJ, Chia CW, Egan J, Allison DB, Churchill GA, Anderson RM, Ferrucci L, Mattison JA, de Cabo R..
.
Item in Clipboard
.
Item in Clipboard
Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.
Sikorska B, Liberski PP.Sikorska B, et al..
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A; REFALS investigators.